BERVASTATIN

Details

Stereochemistry	RACEMIC
Molecular Formula	C28H31FO5
Molecular Weight	466.5411
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCOC(=O)C[C@@H](O)C[C@@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3OC14CCCC4

InChI

InChIKey=ZADJRRFMOOACHL-WQICJITCSA-N

InChI=1S/C28H31FO5/c1-2-33-26(32)18-22(31)17-21(30)13-14-24-27(19-9-11-20(29)12-10-19)23-7-3-4-8-25(23)34-28(24)15-5-6-16-28/h3-4,7-14,21-22,30-31H,2,5-6,15-18H2,1H3/b14-13+/t21-,22-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C28H31FO5
Molecular Weight	466.5411
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	1
Optical Activity	UNSPECIFIED

Description
Sources: https://books.google.ru/books?id=Z_mfTTIApVEC&pg=PA611&lpg=PA611&dq=BERVASTATIN&source=bl&ots=EtFMJsQMCZ&sig=ACfU3U1O3rdxdN9EcTeDJWoL4K2J8tkbdg&hl=ru&sa=X&ved=2ahUKEwiftZ7st4fiAhUPWZoKHX3iAbQ4ChDoATAGegQIBxAB#v=onepage&q=BERVASTATIN&f=false | https://adisinsight.springer.com/drugs/800002290

Bervastatin (also known as LS 2904), a synthetic HMG-CoA reductase inhibitor that was developed for the treatment of hyperlipidemia. However, information about further development is not available.

Originator

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:10:17 UTC 2023` Edited by `admin` on `Fri Dec 15 16:10:17 UTC 2023`
Record UNII	057SF9C1UZ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BERVASTATIN

Official Name

English

ETHYL (±)-(3R*,5S*,6E)-7-(4-(P-FLUOROPHENYL)SPIRO(2H-1-BENZOPYRAN-2,1'-CYCLOPENTAN)-3-YL)-3,5-DIHYDROXY-6-HEPTENOATE

Common Name

English

bervastatin [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1655